Centene Analyst Ratings
Mizuho Adjusts Price Target on Centene to $77 From $76, Maintains Neutral Rating
Argus Research Maintains Centene(CNC.US) With Buy Rating
Wells Fargo Maintains Centene(CNC.US) With Buy Rating, Raises Target Price to $93
Wells Fargo Sticks to Its Buy Rating for Centene (CNC)
Centene Analyst Ratings
Bernstein Adjusts Price Target on Centene to $96 From $94
Centene Analyst Ratings
TD Cowen Adjusts Price Target on Centene to $89 From $80
Truist Financial Maintains Centene(CNC.US) With Buy Rating, Announces Target Price $89
TD Cowen Maintains Centene(CNC.US) With Buy Rating, Raises Target Price to $89
Centene's Upgraded Outlook: Buy Rating With Increased EPS and Price Target
Centene Price Target Cut to $95.00/Share From $110.00 by Oppenheimer
Centene Analyst Ratings
Jefferies Adjusts Price Target on Centene to $74 From $69, Maintains Hold Rating
Oppenheimer Maintains Centene(CNC.US) With Buy Rating, Cuts Target Price to $95
Truist Financial Maintains Centene(CNC.US) With Buy Rating
Truist Financial Keeps Their Buy Rating on Centene (CNC)
Stephens Adjusts Centene Price Target to $78 From $73
Analysts Offer Insights on Healthcare Companies: Centene (CNC), Haleon PLC (GB:HLN) and Ultragenyx Pharmaceutical (RARE)